Uncategorised - European Medical Journal

Continue
23 Dec 2022

Wound Healing in a Time of Antimicrobial Resistance

Karen Ousey joins Jonathan Sackier on this episode of the EMJ Podcast to discuss antimicrobial resistance and wound healing.

Editor's Letter: December 2022

Pharma should double down on its patient centricity efforts to help tackle inequalities in 2023 and beyond, says Helena Beer.

Pharma review of the year 2022

Helena and Isabel are joined by six guests to round off 2022 and Season 3 with a look back at the key highlights of the past 12 months.
12 Mins
20 Dec 2022

Recent Advances in the Management of Gastrointestinal Disease

Interdisciplinary sessions at the recent United European Gastroenterology (UEG) Week, held in Vienna, Austria, from 8th to 11th October 2022, covered new approaches to the diagnosis and treatment of gastrointestinal and hepatic disorders, with a focus on advances in the non-invasive management of these diseases. Abstract-based and poster sessions presented original research from Europe and other parts of the world.
11 Mins
19 Dec 2022

Nothing About Me Without Me: Shared Decision-Making in Chronic Hepatitis B

Hepatitis B affects more than 296 million people worldwide, according to the World Health Organization (WHO). More than 1.5 million new infections occur each year, despite the availability of safe and effective vaccines.

Challenging the postcode health lottery

A postcode can determine health outcomes more than genetics. How can pharma help to solve the postcode lottery?
10 Mins
19 Dec 2022

Prevalence of SARS-CoV-2 Cellular and Humoral Immunity Amongst Patients on Dialysis After the First Vaccination Campaign

Global immunisation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the standard-of-care in preventing COVID-19…
8 Mins
19 Dec 2022

Anti-TNF Treatment in Crohn’s Disease Complicated by Intra-abdominal Abscess

Excess production of TNF-α leads to chronic inflammation and tissue damage in immune-mediated inflammatory diseases (IMID) such as Crohn’s Disease (CD), rheumatoid arthritis, and psoriasis. The introduction of anti-TNF agents revolutionised therapy for patients with IMIDs, and two anti-TNFs are currently approved for use in CD in Europe: infliximab and adalimumab.
16 Dec 2022

Mobile Phone Reminders to Help Improve HIV Treatment Adherence

According to research, weekly mobile phone reminders might be an effective method to increase adherence to antiretroviral therapy…
16 Dec 2022

Optimum Imaging Techniques for Accurate Alzheimer’s Progression

Studies show that machine learning technology can be used to identify the most accurate means of predicting advancement in Alzheimer’s disease